SERUM AMYLOID P-COMPONENT AS A THERAPEUTIC AGENT OR BIOMARKER

摘要

The present invention relates to the treatment of inflammatory diseases and in particular to the provision of therapeutic agents which may halt or slow the progression of inflammatory diseases or disorders. Such diseases include fibrosis, hypertrophy and cardiovascular inflammatory conditions. In particular the agent may be used to halt or slow the progression of hypertensive heart disease into heart failure with preserved ejection fraction. A suitable therapeutic agent is Serum Amyloid P-component. The invention also relates to the use of Serum Amyloid P-component as a biomarker in diagnosing or monitoring the progression of such diseases.